Treatment For Chronic Migraine

Featured Article

The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research, stated,

"Chronic migraine is one of the most disabling forms of headache. Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective...

Read more

More information on "Treatment For Chronic Migraine"

From Our Experts

See more SharePosts »

From Our Sources

More on Migraine »